Company profile for Hi-Tech Pharmacal Co Inc

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

ECR Pharmaceuticals was formed in 1990 with a major focus on respiratory therapies. In June 2014 ECR was acquired by Valeant Pharmaceuticals International, Inc., Bridgewater, NJ. Valeant is a multinational specialty pharmaceutical company that develops and markets prescription and non-prescription pharmaceutical products that make a meaningful difference in patients’ lives. ECR is a branded pharmaceutical company and is a wh...
ECR Pharmaceuticals was formed in 1990 with a major focus on respiratory therapies. In June 2014 ECR was acquired by Valeant Pharmaceuticals International, Inc., Bridgewater, NJ. Valeant is a multinational specialty pharmaceutical company that develops and markets prescription and non-prescription pharmaceutical products that make a meaningful difference in patients’ lives. ECR is a branded pharmaceutical company and is a wholly owned subsidiary of Valeant. ECR products are distributed nationally and are promoted to healthcare professionals by the firm’s sales force and non-personal promotion. The company is positioned to market products that are developed internally and products that are developed externally. ECR continues to pursue differentiated products and technologies that are effective, safe, convenient and affordable.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
P.O. Box 71600 Richmond, VA 23255
Telephone
Telephone
+1 (800) 527-1955 '+1 (804) 527-1950
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.prnewswire.com/news-releases/fine-kaplan-and-black-rpc-announce-class-action-lawsuits-on-behalf-of-those-who-paid-andor-reimbursed-for-generic-clobetasol-between-september-1-2014-and-december-31-2018-or-generic-clomipramine-between-august-1-2013-and--302446187.html

PR NEWSWIRE
06 May 2025

https://www.prnewswire.com/news-releases/hi-tech-pharmaceuticals-to-launch-highly-purified-nmn-nr-product-302179662.html

PR NEWSWIRE
24 Jun 2024

https://www.prnewswire.com/news-releases/hi-tech-pharmaceuticals-increases-production-capacity-for-adderex-xrthe-strongest-otc-focus-aid-ever-developed-that-supports-increased-concentration-focus--productivity-302176356.html

PR NEWSWIRE
19 Jun 2024

https://www.prnewswire.com/news-releases/hi-tech-pharmaceuticals-forms-joint-ventures-to-keep-up-with-demand-of-berberine-cyclosome---a-revolutionary-breakthrough-in-blood-sugar-metabolism-support-and-weight-management-302173116.html

PR NEWSWIRE
17 Jun 2024

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207610

FDA
22 May 2019

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208024

FDA
19 Apr 2019

Inspections and registrations

Upload your audits for free, ask us

ABOUT THIS PAGE

Contact Hi-Tech Pharmacal Co Inc and get a quotation

Hi-Tech Pharmacal Co Inc is a supplier offers 3 products (APIs, Excipients or Intermediates).

Find a price of Ceftriaxone bulk offered by Hi-Tech Pharmacal Co Inc

Find a price of Ertapenem bulk offered by Hi-Tech Pharmacal Co Inc

Find a price of Imipenem bulk offered by Hi-Tech Pharmacal Co Inc

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty